Gamunex Trademark Details

Gamunex was registered on Tuesday, May 13, 2003 and is currently owned by Grifols Therapeutics Inc. under the registration number 2716540 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 11 years ago on Friday, May 24, 2013, according to the United State Patent & Trademark Office
Word Mark Gamunex
Status Alive Registered 800 — Registered and Renewed

Current Owner

Grifols Therapeutics Inc. of Research Triangle Park, NC

View all trademarks for Grifols Therapeutics Inc.
Other Trademarks for Grifols Therapeutics Inc.

Previous Owners

Bayer Corporation of Pittsburgh, PA

View all trademarks for Bayer Corporation
Other Trademarks for Bayer Corporation

Talecris Biotherapeutics, Inc. of Research Triangle Park, NC

View all trademarks for Talecris Biotherapeutics, Inc.
Other Trademarks for Talecris Biotherapeutics, Inc.
Serial Number 78031372
Registration Number 2716540
Status Date Friday, May 24, 2013
Filing Date Friday, May 24, 2013
Registration Date Tuesday, May 13, 2003
Attorney Paul Fields
Domestic Representative Paul Fields

Correspondent

Paul Fields
LEASON ELLIS LLP
One Barker Avenue, Fifth Floor
White Plains NY 10601

Case File Statements

Goods & Services Immune serum globulin

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Thursday, November 16, 2000
First Use Anywhere Thursday, January 9, 2003
First Use In Commerce Thursday, January 9, 2003
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.